Rubius Therapeutics
$4.359876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.10 (+2.35%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours
Why Robinhood?
You can buy or sell RUBY and other stocks, options, ETFs, and crypto commission-free!
About RUBY
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.
Employees
223
Headquarters
Cambridge, Massachusetts
Founded
2013
Market Cap
322.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
314.99K
High Today
$4.59
Low Today
$4.20
Open Price
$4.20
Volume
216.85K
52 Week High
$20.04
52 Week Low
$3.35
Collections
Analyst Ratings
43%
of 7 ratings
Buy
43%
Hold
43%
Sell
14%
RUBY Earnings
-$0.60
-$0.40
-$0.20
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 14, Pre-Market